1 terminated, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow Weekly Paclitaxel: new trials by email Literature Review of Weekly Paclitaxel trials Research Report on Weekly Paclitaxel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling Doxorubicin, Cyclophosphamide, Weekly Paclitaxel - HER2-negative Breast Cancer | Phase 2 | Unknown | NSABP Foundation Inc | 64 | 2018-05-14 | 2023-03-06 |
| Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) Pazopanib, Paclitaxel - Penile Squamous Cell Carcinoma Stage IV | Phase 2 | Terminated | Spanish Oncology Genito-Urinary Group | 4 | 2015-01-01 | 2016-10-14 |
Breast Neoplasms (1)
NSABP Foundation Inc (1) · Spanish Oncology Genito-Urinary Group (1)
Spain (1) · United States (1)
Miguel A Climent, MD (1) · Norman Wolmark, MD (1)
2014 (1)